Serious Injuries Attributed to Zantac®

Based on results of Lab testing, the Food and Drug Administration has learned that Zantac® and other ranitidine based medications have a nitrosamine impurity called N–nitrosodimethylamine (NDMA) at lower concentrations. NDMA is thought of as a probable human carcinogen – a substance might cause cancer in humans. NDMA is a classified environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.


What is NDMA?

N–nitrosodimethylamine (NDMA) is known as a likely human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The research has raised the chance of an connection between NDMA and liver toxicity which may continue to the development of liver cancer and various connected conditions brought about by an NDMA–induced treatment of the liver.


The amount and duration of human NDMA exposure that may lead to the development of cancer is not exactly known. Similarly, the amount and duration of the NDMA contamination of Zantac® and various ranitidine medications are not exactly known.


Diseases Associated with Exposure to NDMA

NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. In light of these studies, the US EPA classifies NDMA as a likely human carcinogen. The studies have increased the probability of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and various associated issues brought about by an NDMA injury to the liver. Others have claimed that NDMA could also be linked to other cancers such as:


Bladder Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.


Has Other Ranitidine Products Also Been Affected?

Yes. The U.S. Food and Drug Administration has informed health care professionals and consumers to three existing voluntary recalls of ranitidine.


Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medicine.

Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride capsules due to the potential of NDMA in the medicine.

Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.

Should I Stop Taking Zantac® or Other Ranitidine Medications?

On zantac lawsuit , 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:


“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”

Consultation

Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to reach out at any time to explore your injury and potential for recovery.